Evidence map›Paper›PMID 39790757›Full record

ArticleJournal of family medicine and primary care2024

Prevalence and control of hypertension in COVID-19 positive cases.

Mohamed O Elamin, Sufian Khalid, Amjed A Ali, Sara O Elamin, Wahaj A Khan, Hatim M Badri, Hatim A Natto, Abdulrahman A Almehmadi, Abdullah Alhazmi, Ahmed Alkathiri and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of family medicine and primary care, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mohamed O ElaminDepartment of Environmental and Occupational Health, Faculty of Public Health and Health Informatics, Umm Al-Qura University, Alziziah Makkah, Saudi Arabia.
Sufian KhalidDepartment of Medicine, Faculty of Medicine, Nile Valley University, Sudan.
Amjed A AliDepartment of Medicine, Faculty of Medicine, Nile Valley University, Sudan.
Sara O ElaminDepartment of Medicine, Faculty of Medicine, Nile Valley University, Sudan.
Wahaj A KhanDepartment of Environmental and Occupational Health, Faculty of Public Health and Health Informatics, Umm Al-Qura University, Alziziah Makkah, Saudi Arabia.
Hatim M BadriDepartment of Environmental and Occupational Health, Faculty of Public Health and Health Informatics, Umm Al-Qura University, Alziziah Makkah, Saudi Arabia.
Hatim A NattoDepartment of Epidemiology and Biostatistics, Faculty of Public Health and Health Informatics, Umm Al-Qura University, Alziziah Makkah, Saudi Arabia.
Abdulrahman A AlmehmadiFaculty of Public Health and Health Informatics, Umm Al-Qura University, Alziziah Makkah, Saudi Arabia.
Abdullah AlhazmiDepartment of Epidemiology and Biostatistics, Faculty of Public Health and Health Informatics, Umm Al-Qura University, Alziziah Makkah, Saudi Arabia.
Ahmed AlkathiriHealth Education and Promotion, Faculty of Public Health and Health Informatics, Umm Al-Qura University, Alziziah Makkah, Saudi Arabia.
Mohamed AlharbiHealth Education and Promotion, Faculty of Public Health and Health Informatics, Umm Al-Qura University, Alziziah Makkah, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The coronavirus disease (COVID-19) is an infectious disease caused by the newly discovered SARS-CoV-2 virus. Patients diagnosed with COVID-19 experience several complications including hypertension or elevated blood pressure which is a serious medical condition that significantly increases the risks of heart, brain, and kidney diseases. Objectives: To assess the prevalence and control of hypertension in COVID-19 patients. Methods: Cross-sectional descriptive hospital-based study conducted in an isolation center at Atbara Teaching Hospital in 2021. The data were collected by interviewing patients through a close-ended questionnaire and analyzed using a statistical computerized program (SPSS version 21). Results: The main results of the study revealed that the prevalence of blood pressure amongst patients diagnosed with COVID-19 was mild 45%, moderate 17.7%, and severe 10%; of the cases, 25.7% were newly discovered hypertension cases, of the cases 26.7% were diabetic patients; and 70.7% of the study group full recovered form COVID-19 at discharge. Conclusion: The study concluded that most of the study group had hypertension with COVID-19, some of them were newly discovered cases of hypertension and also had diabetes mellitus which indicates that COVID-19 may cause the onset of hypertension.

Indexed as

Atbara HospitalCOVID-19cross-sectionalhypertensionisolation centerprevalence

Identifiers

PMID39790757
PMCPMC11709015

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.